CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sichuan Kelun Pharmaceutical Company Limited Company Snapshot
Sichuan Kelun Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sichuan Kelun Pharmaceutical Company Limited with three other companies in this sector in China: Joincare Pharmaceutical Group Industry Company Limited (2017 sales of 10.78 billion Chinese Renmimbi [US$1.56 billion] of which 99% was Industry and Commerce), Harbin Pharmaceutical Group Company Limited (12.02 billion Chinese Renmimbi [US$1.74 billion] of which 66% was Medicine Trade), and China Resources Sanjiu Medical & Pharmaceutical Co Ltd (11.12 billion Chinese Renmimbi [US$1.61 billion] of which 96% was Pharmaceutical).

Sales Analysis. Sichuan Kelun Pharmaceutical Company Limited reported sales of 11.43 billion Chinese Renmimbi (US$1.65 billion) for the year ending December of 2017. This represents an increase of 33.5% versus 2016, when the company's sales were 8.57 billion Chinese Renmimbi. Sales of Medical and Pharmaceutical Products saw an increase of 37.6% in 2017, from 8.23 billion Chinese Renmimbi to 11.33 billion Chinese Renmimbi. Not all segments of Sichuan Kelun Pharmaceutical Company Limited experienced an increase in sales in 2017: sales of Other Operating fell 68.6% to 104.39 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sichuan Kelun Pharmaceutical Company Limited
  Stock Performance Chart for Sichuan Kelun Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 23.68
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks -2.5%  
4 Weeks -29.3%   52 Weeks 21.4%  
 
Sichuan Kelun Pharmaceutical Company Limited Key Data:
  Ticker: 002422 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 11,434,948,841
(Year Ending Jan 2018).
Employees: 18,289
  Currency: Chinese Renmimbi Market Cap: 34,099,200,000
  Fiscal Yr Ends: December Shares Outstanding: 1,440,000,000
  Share Type: A GU Closely Held Shares: 784,687,212
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.